After years of waiting, patients with non-radiographic axial spondyloarthritis (nr-axSpA) can officially be prescribed biologic medications in the US. Since the beginning of the year, three biologic medications have been approved by the FDA for people with nr-axSpA: Cimzia, Taltz, and Cosentyx. As someone who spent years waiting for diagnosis and treatment, I’m excited by the game-changing potential of nr-axSpA treatments being officially recognized. nr-axSpA? Spondyloarthritis (SpA) is a group of autoimmune arthritis conditions that affect the spine, other joints, and entheses. Ankylosing spondylitis (AS) is the most well-known (and easily diagnosed) type, but it requires joint damage to be visible on imaging. This leaves doctors with a conundrum: how…